Grampian Biopartners is a angel investment group and venture capital firm that invests in companies operating in the biologic drug discovery, antibody, alternative scaffold, protein, peptide, regenerative medicine, immuno-diagnostics device and immuno-platform technology sectors. The firm was established in 2008.